Mrv1909 12031917542D 19 20 0 0 0 0 999 V2000 -1.1579 0.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1579 -0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4434 -0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4434 0.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2710 0.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2710 -0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0558 -0.5569 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.5408 0.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0558 0.7780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3659 0.1105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7783 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6035 0.8251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3659 1.5395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0160 1.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8724 -0.7145 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -2.5870 -0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8724 -1.5395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3014 -0.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0160 -0.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6 7 1 0 0 0 0 4 1 1 0 0 0 0 8 10 1 0 0 0 0 5 6 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 2 3 1 0 0 0 0 11 13 2 0 0 0 0 3 6 2 0 0 0 0 12 14 1 0 0 0 0 1 2 2 0 0 0 0 2 15 1 0 0 0 0 5 4 2 0 0 0 0 15 16 1 0 0 0 0 7 8 2 0 0 0 0 15 17 2 0 0 0 0 8 9 1 0 0 0 0 16 18 1 0 0 0 0 9 5 1 0 0 0 0 18 19 1 0 0 0 0 M END > DB13871 > drugbank > CCCS(=O)C1=CC=C2NC(NC(=O)OC)=NC2=C1 > InChI=1S/C12H15N3O3S/c1-3-6-19(17)8-4-5-9-10(7-8)14-11(13-9)15-12(16)18-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) > VXTGHWHFYNYFFV-UHFFFAOYSA-N > C12H15N3O3S > 281.331 > 281.083412051 > 4 > 34 > 29.48440376264424 > 1 > 2 > 0 > 1 > methyl N-[5-(propane-1-sulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate > 1.18 > 1.5656897129999998 > -2.49 > 0 > 2 > 0 > 13.929161176659264 > 9.261175353999844 > 3.579538144529193 > 84.07999999999998 > 74.53479999999999 > 5 > 1 > 9.01e-01 g/l > topramezone > 0 > DB13871 > experimental > Albendazole oxide > (±)-albendazole sulfoxide; Albendazole oxide; Albendazole S-oxide; Albendazole sulfoxide; Methyl 5-(propylsulfinyl)-2-benzimidazolecarbamate; Ricobendazole; Rycobendazole $$$$